Apr 08, 2024 / 12:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to Abivax conference call to discuss 2023 financial results and business update. My name is Sandra and I will be your operator for today's call. (Operator Instructions)
As a reminder, this call is being recorded at Abivax's request. Now I would like to introduce your host for today's call, Patrick Malloy, Senior Vice President, Investor Relations. Pat, please go ahead.
Patrick Malloy - Abivax SA - SVP, IR
Good morning and good afternoon, everyone. Welcome to today's call during which we'll provide an update on our financial results for the full year ended December 31, 2023. As well as key program updates across business.
On April 2, we issued a press release summarizing our financial results. And April 5, we filed our 20-F and universal registration document, all of which can be found on the Abivax website.
Before we get started, I'd like to remind everyone that during today's discussion, we'll make statements about our future expectations, plans and prospects that
Full Year 2023 Abivax SA Earnings Call Transcript
Apr 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers